AVTR Avantor NYSE -0.62% after-hours 10 Feb 2026: earnings may set the next trading range

Shares of Avantor, Inc. (AVTR) trade at USD 11.16 after-hours as investors position ahead of the company’s earnings report due 11 Feb 2026. The focus keyword AVTR stock is central today because trading volume is elevated at 28,607,481.00 shares and the market is parsing guidance and turnaround progress. Wall Street consensus sits near a USD 13.60 average target, while recent analyst moves and insider activity add nuance to the near-term outlook.

AVTR stock: earnings snapshot and timing

Avantor reports after the close on 11 Feb 2026. Analysts expect adjusted EPS near USD 0.22 and revenue down roughly 2.9% year-over-year, according to previews. That estimate will be the primary driver for short-term moves because the company has flagged margin recovery and cost actions in prior updates.

Analyst price targets and consensus

Street targets for Avantor range from USD 12.00 to USD 17.00, with a MarketBeat average target of USD 13.60. Recent notes include downgrades to USD 12.00 by some firms and an outperform view at USD 17.00. Those targets frame a consensus that the stock trades at a modest premium to near-term fundamentals but below peak valuations.

Key financials and valuation metrics

Avantor shows revenue per share USD 9.65, EPS -0.13, and a market cap of USD 7,605,644,752.00. Price-to-sales is 1.17, price-to-book is 1.38, and trailing PE is negative at -85.81. Net debt to EBITDA is elevated at 5.59, and interest coverage is thin at 1.52, which keeps credit and leverage front of mind for analysts and investors.

Technical setup and trading flow for AVTR stock

Momentum indicators show an RSI of 66.76, MACD histogram 0.14, and MFI 82.06, pointing to short-term strength but overbought readings. The stock sits near its 50-day average USD 11.51 and below the 200-day average USD 12.60, making the earnings print a likely trigger for a move toward the 200-day or a re-test of the 52-week low USD 10.62.

Meyka AI rates AVTR with a score out of 100 and model forecast

Meyka AI rates AVTR with a score out of 100: 68.76 (Grade B, Suggestion: HOLD). This grade factors in S&P 500 comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a 12‑month value of USD 6.44, which implies downside versus the current price. These model-based results are probabilistic and not guarantees. For context and further reading see the MarketBeat forecast and an earnings preview on Investing.com source source.

Risks and catalysts ahead of the report

Catalysts include clearer guidance, margin cadence and order trends in biopharma and applied materials. Risks are leverage, weak free cash flow conversion and any slowdown in lab consumables demand. Institutional moves and insider purchases are additional inputs; a December director purchase at USD 11.09 is notable but small relative to institutional ownership at about 95.08%.

Final Thoughts

Key takeaways: AVTR stock trades at USD 11.16 after-hours on 10 Feb 2026 with heavy volume as investors await results. Fundamentals show mixed signals: stable revenue per share USD 9.65 and positive operating cash flow per share USD 0.95, but negative trailing EPS and high net-debt-to-EBITDA 5.59. Wall Street targets center near USD 13.60 while Meyka AI’s forecast model projects USD 6.44, implying a model-based downside of -42.29% versus the current price. Our Meyka grade of 68.76 (B, HOLD) weighs sector comparisons, growth and analyst sentiment. Watch the earnings print for guidance on margins and working capital; the report should set the next trading range and clarify whether the stock confirms analyst cautiousness or re-rates toward the buy-target end of the range. Forecasts are model-based projections and not guarantees. For the latest filings and analyst notes visit our AVTR page on Meyka AI source and the MarketBeat forecast source.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.